Modelling prolactin signalling and its interactions with other cancer-related signalling pathways Maria Luisa Guerriero Prolactin is a hormone involved in many physiological processes, including lactation, growth and development, and immumomodulation, and it acts as a growth, differentiating and survival factor. The increased level of prolactin expression present in breast cancer cells is known to be implicated in the resistance of breast cancer to chemotherapy, thus making prolactin an interesting target for cancer biology studies. Acting both as a cytokine and as a growth factor, prolactin activates many signalling pathways, including the JAK/STAT pathway, the PI3K/Akt, and the Ras/Raf/MEK/Erk pathway. Recently, a strong Ras-independent Erk activation has also been observed in breast cancer cells. In this talk I will present a computational model of prolactin signalling in breast cancer cells, which includes various cross-talk and feedbacks occurring among the various activated pathways. In order to show how this work fits in the bigger picture of cancer biology, I will also introduce a detailed computational model of cancer-related signalling aimed at the identification of possible novel drug targets, which is being developed as an on-going effort involving several researchers in our group.